Government Pricing New Government Pricing Tools: Unraveling the Complexities of Government Pricing December 10, 2024 Carina WangSenior Product Manager Jonathan BrierVice President Product Line Manager 2 Minute Read The pharmaceutical industry operates in a highly regulated environment, and government pricing is a critical aspect of compliance. Recent regulatory changes and increasing complexity have made it challenging for manufacturers to accurately calculate and report their government prices. What is Reallocation? Reallocation is a process where manufacturers must proportionally allocate discounts associated with bundled product sales. This ensures that the discounts are accurately assigned to individual products, allowing for precise government price calculations. Why is Reallocation Important? Compliance: Proper reallocation is essential to adhere to government regulations, particularly the Deficit Reduction Act, which provides specific guidelines for discount allocation. Accurate Reporting: Accurate reallocation ensures that manufacturers report correct data to government agencies, avoiding potential penalties and legal issues. Strategic Decision-Making: By understanding the impact of different contracting strategies, manufacturers can make informed decisions about their pricing and discounting practices. Types of Bundles and Reallocation Single Multi-Period Bundle: This involves one or multiple products within a single contract for all customers or specific customer groups. Reallocation is typically done within a specific period, such as a year. Fixed Period Bundle: This type of bundle considers discounts within a fixed date range, regardless of product or customer. Reallocation is based on this fixed period. Temporal Bundle: In this scenario, rebates are contingent on prior period performance. Reallocation becomes more complex as it involves linking current period discounts to past performance data. The Reallocation Process and Its Impact on Price Calculations Reallocation is a crucial step before calculating government price types like AMP, BP, and others. It ensures that the transactional data used in these calculations accurately reflects the discounts associated with each product. Stacking and Blending: Key Concepts in Reallocation Stacking: This involves identifying and grouping transactions to calculate net price points for best price calculations. It helps determine the actual price paid by the customer, considering various discounts and fees. Blending: This process groups related products, such as relabels or authorized generics, to calculate their respective price points. Navigating the Complexities of Government Pricing Manufacturers can effectively navigate the complexities of government pricing by: Leveraging Advanced Technology: Employing specialized software solutions can automate reallocation, stacking, and blending processes, reducing errors and ensuring compliance. Partnering with Experts: Consulting with experts in government pricing can provide valuable insights and guidance on regulatory requirements and best practices. Staying Informed: Keeping abreast of regulatory changes and industry trends is essential to adapting pricing strategies and maintaining compliance. By understanding the intricacies of reallocation, stacking, and blending, pharmaceutical manufacturers can make informed decisions, optimize their pricing strategies, and ensure long-term success in the government market. IntegriChain now offers Discount Reallocation, Price Stacking and Product Blending solutions. For more information on pricing strategies, contact sales@integrichain.com About the Author Carina Wang Senior Product Manager Carina Wang is a dynamic Senior Product Manager at IntegriChain, specializing in Government Pricing solutions within the pharmaceutical sector. With over eight years of expertise in product management, system implementation, and cross-functional team leadership, she has a proven ability to drive strategic initiatives and deliver impactful results. Carina’s experience spans both the pharmaceutical and software industries, with a focus on requirements analysis, strategic product roadmap development, and effective stakeholder engagement to achieve organizational objectives. About the Author Jonathan Brier Vice President Product Line Manager Jon Brier is Vice President of Product Management responsible for IntegriChain’s Contract & Pricing solution, Gross-to-Net (GTN) solutions, and the analytics offerings for both Contracts & Pricing and GTN. Jon has more than 24 years of experience in the life science industry. He has spent the last four years at IntegriChain working with the module-specific product managers building and enhancing the Contract & Pricing and GTN applications to ensure innovations are being incorporated into the solutions to maximize the value of the ICyte application. He works with users to build out product roadmaps as well as new analytical reports to further drive value from the ICyte solution. Prior to IntegriChain, Jon spent 16 years at iMany/Revitas/Model N, building the revenue management application focused primarily on the commercial rebating needs for chargeback, PBR, and managed care processing. Later, Jon was responsible for managing the entire revenue management offering for Model N. He earned a BA degree from Washington University in St. Louis and an MBA degree from Northeastern University.
Corporate December 10, 2024 Expansion of Data Quality Monitoring and Inventory Roll Forward 2 Minute Read
Contracts & Pricing December 10, 2024 Navigating DSCSA Compliance: Overcoming Challenges in the Pharmaceutical Supply Chain 4 Minute Read